The women’s health and wellness space is booming. The opportunities are real and so are the rewards. This is where you keep up. Welcome to The DXF Edit.

This Week’s Hot Topics:

✧ Private equity bought the gold standard in breast cancer screening.

✧ A Texas law reached across state lines to sue a California doctor.

✧ A smart menstrual cup raised $9 million.

✧ Gen Z is obsessed with trackers.

Money Moves

Private Equity Just Took Over the Biggest Name in Breast Cancer Screening.

Blackstone and TPG completed their acquisition of Hologic on April 7, taking the women’s health company private in a $17 billion buyout, the largest PE take-private in medtech in two decades.

Private equity sees recurring, essential revenue in tools women cannot opt out of needing. Will removing public accountability accelerate and increase innovation, or just the margins?

Women’s Health Is a $1 Trillion Opportunity. It Currently Gets 6% of Private Healthcare Investment.

Two major reports landed this week naming the same gap. A PwC report sizes the women’s health market at $600 billion by 2030. The WEF’s Women’s Health Investment Outlook puts it at $1 trillion and confirms women’s health captures only 6% of private healthcare investment. Conditions like endometriosis, PCOS, and menopause receive under 2% of private funding.

The money is starting to follow. Venture investment in women’s health hit a record $2.6 billion in 2024, up 55% year over year. Companies aren’t closing this gap out of goodwill. They found the return.

Quick Hit:

• Maven Clinic is going direct-to-consumer in May. Whether it’s actually accessible depends on a price they haven’t announced yet.

Innovation

The World’s First Smart Menstrual Cup Just Raised $9M. It Already Has 30,000 Pre-Orders.

Founder Jenny Button noticed she could get detailed health data from her Oura ring and Whoop band, but nothing about her reproductive health. Five years later, the answer is a sensor-embedded menstrual cup that tracks flow volume and cycle patterns. Emm is building that dataset, one cycle at a time.

Menstruation is called the fifth vital sign, and while we do need more data, it’s unclear how reliable or useful the data Emm is collecting will be. It’s definitely a step in the right direction though.

The Science Is Finally Catching Up to the GLP-1 and HRT Combination.

Before the clinical establishment had a protocol, women in perimenopause and menopause were already reporting better results on GLP-1 medications when they added hormone therapy. Telehealth platforms built combined treatments to meet the demand. A January 2026 Mayo Clinic study published in The Lancet found that postmenopausal women on both HRT and tirzepatide lost approximately 35% more weight than those on tirzepatide alone. For most women, the combination is considered safe under medical supervision but GLP-1s reduce both fat and muscle mass, and perimenopausal women already face an elevated risk for muscle and bone density loss. Randomised trials are underway, and the evidence is promising!

Quick Hit:

• The FDA stripped cardiovascular, breast cancer, and dementia risk warnings from hormone therapy labels in February, reversing the fallout from a 2002 study that scared millions of women off HRT for two decades.

Law & Policy

Abortion bans aren’t working. And the number proves it.

A Guttmacher Institute report published March 24th found there were an estimated 1,126,000 abortions in the US in 2025, essentially unchanged from 2024. Four years of bans, and the number has not moved, even though a lot has changed. Everything changed: the routes, the costs, the risk, who has to carry it and how far. Women are still getting abortions. They are just doing it in ways that are harder, more expensive, more frightening, and more legally precarious than before. The bans did not stop abortion. They just made it something women have to fight for.

Texas Just Built a Legal Tool to Reach Abortion Access Across State Lines.

Texas already has one of the strictest abortion bans in the country. HB7 is an escalation, and a new kind of one. Rather than state prosecution, it arms private citizens: anyone can sue anyone who provides abortion medication to women in Texas, with a minimum penalty of $100,000 per incident.

The cases are stacking up. On February 1st, a California doctor became the first person sued under HB7 by a private citizen claiming he prescribed pills used by his former girlfriend to end a pregnancy. Weeks later, AG Ken Paxton filed suit against Aid Access, an Austria-based nonprofit, seeking to block it from serving Texas residents entirely. A New York judge has since dismissed a similar Texas attempt to fine a New York doctor, an early sign shield laws are holding. For now.

On The Feed

Gen Z Is the Most Active Health Tracker

45% of Gen Zers and 35% of millennials use social media as a health resource, compared with 24% of Gen Xers and 6% of baby boomers. According to the 2025 Edelman Trust Barometer, younger adults are twice as likely to take health guidance from non-medical voices, and 38% have ignored their provider in favor of social media advice in the past year. Women aged 25 to 30 are now the most active health trackers, 40% more engaged than those in their 30s. The structural implication: the youngest and most digitally engaged generation of women has effectively opted out of the medical establishment as a primary health authority. The feed is not supplementing their healthcare. For many, it is replacing it.

Egg Freezing Goes Mainstream

California’s SB 729, effective January 2026, requires large-group insurance plans to cover IVF and up to three egg retrievals, but only for women medically diagnosed with infertility. However, elective egg freezing is explicitly excluded. Women in their late 20s and early 30s are sharing their egg-freezing journeys on TikTok in real time from costs, hormone injections, to retrieval results. Rita Ora revealed in a March 2026 Women’s Health UK interview that she froze her eggs at 24 and 27, describing it as the best advice she received. The celebrity disclosure and the insurance gap are the same conversation. The feed has already made egg freezing a normalized planning decision.

DXF Recs

What DXF is watching — products, companies, and tools moving in women’s health right now.

Rhode Glazing Milk — $38 — Ceramides, hyaluronic acid, beta-glucan. The most repurchased step in Hailey Bieber’s routine, arguably un-dupable and can be hard to get your hands on.

Jolie Filtered Showerhead — $165 + $30/3 months — Filters chlorine and heavy metals from shower water, which can affect your hair and skin.

Red Light Panel — 660nm and 850nm wavelengths. Skin, recovery, inflammation, sleep. Three price points:

• Entry: Hooga HG300 — $75
• Mid: NovaaLab Pad XL — $400
• Premium: Bon Charge Max — $999

Ovasitol Inositol — $50/month — The most discussed PCOS supplement on TikTok, and the hype is fully backed by research! Restores ovulation, improves insulin sensitivity, and reduces androgen symptoms.

Thorne Magnesium Bisglycinate — $28/month — Sleep, anxiety, PMS, perimenopause. Reputable and third-party tested. Start here if you are not sleeping well.

Momentous Creatine — $40 — NSF Certified for Sport. Developed with Dr. Stacy Sims. Muscle strength, recovery, cognitive performance.